Financials Nanjing Sinolife United Company Limited
Equities
3332
CNE100001S08
Other Specialty Retailers
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.54 HKD | 0.00% | +18.68% | +134.78% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 319.9 | 177.6 | 126.6 | 121.1 | 98.62 | 197.8 |
Enterprise Value (EV) 1 | 138.9 | 110.3 | 57.5 | 53.69 | 56.18 | 110.2 |
P/E ratio | -2.84 x | -0.91 x | -2.55 x | -3.82 x | -6.92 x | 3.76 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.71 x | 0.55 x | 0.43 x | 0.48 x | 0.36 x | 0.35 x |
EV / Revenue | 0.31 x | 0.34 x | 0.19 x | 0.21 x | 0.2 x | 0.2 x |
EV / EBITDA | -2.76 x | -1.11 x | -2.06 x | -1.74 x | -11.5 x | 1.73 x |
EV / FCF | 79.5 x | -2.37 x | -4.61 x | -4.38 x | 18.9 x | 5.21 x |
FCF Yield | 1.26% | -42.2% | -21.7% | -22.8% | 5.28% | 19.2% |
Price to Book | 0.53 x | 0.43 x | 0.35 x | 0.37 x | 0.3 x | 0.52 x |
Nbr of stocks (in thousands) | 946,298 | 946,298 | 946,298 | 946,298 | 946,298 | 946,298 |
Reference price 2 | 0.3381 | 0.1877 | 0.1338 | 0.1279 | 0.1042 | 0.2090 |
Announcement Date | 4/18/19 | 4/16/20 | 4/22/21 | 4/22/22 | 4/21/23 | 4/19/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 453.2 | 322.6 | 296.5 | 252.3 | 274.9 | 564 |
EBITDA 1 | -50.33 | -99.25 | -27.87 | -30.82 | -4.884 | 63.54 |
EBIT 1 | -62.76 | -115.8 | -43.89 | -45.59 | -16.22 | 52.9 |
Operating Margin | -13.85% | -35.88% | -14.8% | -18.07% | -5.9% | 9.38% |
Earnings before Tax (EBT) 1 | -127.1 | -181.6 | -44.16 | -33.1 | -10.5 | 58.09 |
Net income 1 | -112.8 | -194.7 | -49.6 | -31.71 | -14.25 | 52.6 |
Net margin | -24.9% | -60.34% | -16.73% | -12.57% | -5.18% | 9.33% |
EPS 2 | -0.1192 | -0.2057 | -0.0524 | -0.0335 | -0.0151 | 0.0556 |
Free Cash Flow 1 | 1.747 | -46.59 | -12.46 | -12.26 | 2.969 | 21.14 |
FCF margin | 0.39% | -14.44% | -4.2% | -4.86% | 1.08% | 3.75% |
FCF Conversion (EBITDA) | - | - | - | - | - | 33.28% |
FCF Conversion (Net income) | - | - | - | - | - | 40.2% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 4/18/19 | 4/16/20 | 4/22/21 | 4/22/22 | 4/21/23 | 4/19/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 181 | 67.3 | 69.1 | 67.4 | 42.4 | 87.6 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 1.75 | -46.6 | -12.5 | -12.3 | 2.97 | 21.1 |
ROE (net income / shareholders' equity) | -17.1% | -38.4% | -12.8% | -9.16% | -4.36% | 15% |
ROA (Net income/ Total Assets) | -4.85% | -11.3% | -5.53% | -6.79% | -2.45% | 7.02% |
Assets 1 | 2,324 | 1,727 | 897.3 | 467.3 | 581.4 | 749.7 |
Book Value Per Share 2 | 0.6400 | 0.4300 | 0.3800 | 0.3500 | 0.3400 | 0.4000 |
Cash Flow per Share 2 | 0.2100 | 0.1100 | 0.0800 | 0.0800 | 0.0800 | 0.1200 |
Capex 1 | 51.1 | 20.9 | 13.2 | 10.1 | 3.86 | 2.35 |
Capex / Sales | 11.27% | 6.49% | 4.45% | 4% | 1.41% | 0.42% |
Announcement Date | 4/18/19 | 4/16/20 | 4/22/21 | 4/22/22 | 4/21/23 | 4/19/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+134.78% | 65.47M | |
-.--% | 843M | |
+6.30% | 715M | |
+30.62% | 476M | |
+30.87% | 259M | |
0.00% | 128M |
- Stock Market
- Equities
- 3332 Stock
- Financials Nanjing Sinolife United Company Limited